Skip to main content
Log in

Urinary excretion of N-acetyl-beta-D-glucosaminidase in newly diagnosed essential hypertensive patients and its changes with effective antihypertensive therapy

  • Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adler SG. Biochemical investigation of urine. In: Massry SG, Glassock R, editors, Textbook of nephrology, 3rd edn. Baltimore: Williams and Wilkins, 1995: 1774–1775.

    Google Scholar 

  2. Price RG. Urinary N-acetyl-β-D-glucosaminidase (NAG) as an indicator of renal disease. Curr Probl Clin Biochem 1979; 9: 150–163.

    PubMed  CAS  Google Scholar 

  3. Alderman MH, Melcher L, Drayer DE, Reidenberg MM. Increased excretion of urinary N-acetyl-β-D-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med 1983; 309: 1213–1217.

    Article  PubMed  CAS  Google Scholar 

  4. Simon G, Peterson S. Pathophysiology of increased urinary N-acetyl-β-D-glucosaminidase activity in human hypertension: Effect of cilazapril therapy. Clin Exp Hypertens 1988; 10(5): 767–777.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harmankaya, Ö., Öztürk, Y., Bastürk, T. et al. Urinary excretion of N-acetyl-beta-D-glucosaminidase in newly diagnosed essential hypertensive patients and its changes with effective antihypertensive therapy. Int Urol Nephrol 32, 583–584 (2001). https://doi.org/10.1023/A:1014443217611

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014443217611

Keywords

Navigation